![Derek DiRocco](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Derek DiRocco
Directeur/Membre du Conseil chez
EVOMMUNE, INC.
Fortune : 14 986 $ au 31/05/2026
Profil
Derek DiRocco is currently Director at Suzhou Connect Biopharma Co. Ltd., 89Bio Ltd., Rivus Pharmaceuticals, Inc., Forward Therapeutics, Inc., and Sera Medicines LLC.
Holds Independent Director roles at Acrivon Therapeutics, Inc. since 2021, Mineralys Therapeutics, Inc. since 2022, and Evommune, Inc. since 2024.
Partner at RA Capital Management LP (Private Equity) since 2020.
Former roles include Independent Director at iTeos Therapeutics, Inc. (2020–2023), Non-Executive Director at CANbridge Pharmaceuticals Inc. (2020–2023), Independent Non-Executive Director at Achilles Therapeutics Plc (2019–2022), Independent Director at Werewolf Therapeutics, Inc. (2020–2025), Independent Director at 89bio, Inc. (2018–2025), Non-Executive Director at Achilles Therapeutics UK Ltd., Independent Director at Day One Biopharmaceuticals, Inc., Director at Canbridge Pharmaceuticals, Inc. (United States), and Independent Non-Executive Director at Connect Biopharma Holdings Ltd. Education includes undergraduate degree from College of the Holy Cross (Massachusetts) in 2002 and doctorate from the University of Washington in 2009.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 17/06/2026 | 9 366 ( 0,02 % ) | 14 986 $ | 31/05/2026 | |
| 25/03/2026 | 0 ( -.--% ) | - $ | 31/05/2026 | |
| 14/04/2025 | 0 ( -.--% ) | - $ | 31/05/2026 |
Postes actifs de Derek DiRocco
| Sociétés | Poste | Début |
|---|---|---|
| ACRIVON THERAPEUTICS, INC. | Directeur/Membre du Conseil | 01/11/2021 |
| MINERALYS THERAPEUTICS, INC. | Directeur/Membre du Conseil | 08/05/2022 |
| EVOMMUNE, INC. | Directeur/Membre du Conseil | 01/10/2024 |
RA Capital Management LP
 RA Capital Management LP Investment ManagersFinance RA Capital is a multi-stage investment manager that focuses evidence-based investing in public and private healthcare and life science companies which develops drugs, medical devices, diagnostics, services, and research tools. The firm’s portfolio of private and public companies spans the globe and most therapeutic areas across all stages from discovery through commercialization. | Analyst-Equity | 01/07/2013 |
Forward Therapeutics, Inc.
 Forward Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops immunology drugs | Directeur/Membre du Conseil | - |
Rivus Pharmaceuticals, Inc.
 Rivus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Directeur/Membre du Conseil | - |
Suzhou Connect Biopharma Co. Ltd.
 Suzhou Connect Biopharma Co. Ltd. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops innovative therapies that treat inflammatory diseases | Directeur/Membre du Conseil | - |
89Bio Ltd.
 89Bio Ltd. Pharmaceuticals: MajorHealth Technology Develops therapies and drugs for treatments of patients living with nonalcoholic steatohepatitis | Directeur/Membre du Conseil | - |
RA Capital Management LP (Private Equity)
 RA Capital Management LP (Private Equity) Investment ManagersFinance RA Capital invests in both public and private companies located in the United States. The firm targets companies operating in the fields of healthcare and life sciences. It provides financing for pre-seed, seed stage, early stage and growth capital requirements . The firm acts as a lead and co-investor, makes follow-on investments and has a board seat requirement. | Private Equity Investor | 01/12/2017 |
Anciens postes connus de Derek DiRocco
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
Formation de Derek DiRocco
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
79
Relations au 1er degré
20
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 20 |
|---|---|
RA Capital Management LP
RA Capital Management LP Investment ManagersFinance RA Capital is a multi-stage investment manager that focuses evidence-based investing in public and private healthcare and life science companies which develops drugs, medical devices, diagnostics, services, and research tools. The firm’s portfolio of private and public companies spans the globe and most therapeutic areas across all stages from discovery through commercialization. | Finance |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
College of the Holy Cross (Massachusetts)
 College of the Holy Cross (Massachusetts) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Achilles Therapeutics UK Ltd.
 Achilles Therapeutics UK Ltd. BiotechnologyHealth Technology Develops personalized vaccines and adoptive T cell therapies to treat metastatic cancer | Health Technology |
Suzhou Connect Biopharma Co. Ltd.
Suzhou Connect Biopharma Co. Ltd. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops innovative therapies that treat inflammatory diseases | Health Technology |
89bio, Inc.
 89bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
89Bio Ltd.
89Bio Ltd. Pharmaceuticals: MajorHealth Technology Develops therapies and drugs for treatments of patients living with nonalcoholic steatohepatitis | Health Technology |
Werewolf Therapeutics, Inc.
 Werewolf Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures medicines for cancer | Health Technology |
RA Capital Management LP (Private Equity)
RA Capital Management LP (Private Equity) Investment ManagersFinance RA Capital invests in both public and private companies located in the United States. The firm targets companies operating in the fields of healthcare and life sciences. It provides financing for pre-seed, seed stage, early stage and growth capital requirements . The firm acts as a lead and co-investor, makes follow-on investments and has a board seat requirement. | Finance |
Canbridge Pharmaceuticals, Inc. (United States)
 Canbridge Pharmaceuticals, Inc. (United States) BiotechnologyHealth Technology Operates as a biopharmaceutical company which research, development and commercialization of transformative therapies | Health Technology |
iTeos Therapeutics, Inc.
 iTeos Therapeutics, Inc. BiotechnologyHealth Technology Develops immunomodulators for cancer treatments | Health Technology |
Rivus Pharmaceuticals, Inc.
Rivus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Acrivon Therapeutics, Inc.
 Acrivon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that develops and sells precision oncology medicines | Health Technology |
Evommune, Inc.
 Evommune, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biotechnology company that develops therapies for chronic inflammatory diseases | Health Technology |
Day One Biopharmaceuticals, Inc.
 Day One Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biopharmaceutical company which develops and commercializes targeted therapies for cancers | Health Technology |
Connect Biopharma Holdings Ltd.
 Connect Biopharma Holdings Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Achilles Therapeutics Plc
 Achilles Therapeutics Plc Pharmaceuticals: MajorHealth Technology Develops and sells cancer immunotherapies | Health Technology |
Mineralys Therapeutics, Inc.
 Mineralys Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company which develops medicines to target diseases | Health Technology |
CANbridge Pharmaceuticals Inc.
 CANbridge Pharmaceuticals Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Forward Therapeutics, Inc.
Forward Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops immunology drugs | Health Technology |
